Search…

Changshan Pharmaceutical: The clinical trials of Aibonapeptide for weight loss indications have not completed the preparation work yet.

11/03/2026

Changshan Pharmaceutical stated on March 11th on the interactive platform that the clinical trial of Aibinapeptide for weight loss indications has not yet completed preparations, and conducting weight loss clinical trials does not require waiting for the approval results of hypoglycemic indications.

Latest

3 m ago

Analyst: Rheinmetall's ability to rapidly expand production capacity is being questioned.

4 m ago

UK Chancellor of the Exchequer Rishi Sunak: The supercharging network policy currently provides a 60% discount for approximately 500 companies, and we will expand this discount to 90%, which will be implemented starting from April of this year. Starting from April next year, we will launch a new plan benefiting around 7,000 companies.

6 m ago

During specific target research, Fu Erjia stated that the clinical trial of the recombined Type III humanized collagen freeze-dried fibers has been completed and a clinical trial summary report has been obtained. They are currently preparing to submit application materials.

6 m ago

In the past three years, the supervisory department in Shanghai has handled 58 cases of infringement of trade secrets, with a total fine of nearly 5 million yuan.

7 m ago

Sources say that the Black Sea CPC blend crude oil's March export volume has been reduced from the initial plan of 1.7 million barrels per day to approximately 1.4-1.5 million barrels per day.

See all latest